Contributions of hippocampal cellular damage and NMDA receptor dysfunction to behavioral markers of schizophrenia

International Journal of Neuroscience

Volumn 109, Issue 1-2, 2001, Pages 61-70

  Finamore, T L ^a   Seybold, K S ^a   Noble, M ^a   Port, R L ^a  

^a KENT STATE UNIVERSITY   (United States)

Author keywords

Habituation; Prepulse inhibition; Pyramidal neurons; Startle

Indexed keywords

EID: 0034841134     PISSN: 00207454     EISSN: None     Source Type: Journal    
DOI: 10.3109/00207450108986525     Document Type: Article

References (33)

1. The NMDA antagonist model for schizophrenia: Promises and pitfalls
2. Multiple limbic regions mediate the disruption of prepulse inhibition produced in rats by the noncompetitive NMDA antagonist dizocilpine
3. Glutamate agonist activity: Implications for antipsychotic drug action and schizophrenia
4. Kainic acid decreases hippocampal neuronal number and increases dopamine receptor binding in the nucleus accumbens: An animal model of schizophrenia
5. The effects of kainic acid lesions on locomotor responses to haloperidol and clozapine
6. Anterior hippocampal volume reductions predict frontal lobe dysfunction in first episode schizophrenia
7. Gating and habituation of the startle reflex in schizophrenic patients
8. Prestimulus effects on human startle reflex in normals and schizophrenics
9. Brain morphology and schizophrenia: A magnetic resonance imaging study of limbic, prefrontal cortex and caudate structures
10. Schizophrenia and the hippocampus: The embryological hypothesis extended
11. Free operant and T-maze avoidance performance by septal and hippocampal damaged rats
12. Cerebrospinal fluid glutamate inversely correlates with positive symptom severity in unmedicated male schizophrenic/schizoaffective patients
13. Abolition of latent inhibition in acute but not chronic schizophrenics
14. Startle gating deficits occur across prepulse intensities in schizophrenia patients
15. Long-term potentiation in the hippocampus involves activation of the N-methyl-d-aspartate receptors
16. The role of N-Methyl-D-Aspartate receptor mediated neurotransmission in the pathophysiology and therapeutics of psychiatric syndromes
17. The glutamate hypothesis of schizophrenia
18. Sensory gating deficits in schizophrenia: New results
19. Acoustic startle, prepulse inhibition, locomotion and latent inhibition in the neuroleptic-responsive (NR) and neuroleptic-nonresponsive (NNR) lines of mice
20. A neurohistological correlate of schizophrenia
21. Effects of phencyclidine and phencyclidine biologs on sensory gating in the rat
22. Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging
23. Ketamine induced NMDA receptor hypofunction as a model of memory impairment and psychosis
24. Partial hippocampal pyramidal cell loss alters behavior in rats: Implications for an animal model of schizophrenia
25. Hippocampal synaptic plasticity as a biological substrate underlying episodic psychosis
26. Latent inhibition of the classically conditioned rabbit nictitating membrane response is unaffected by the NMDA antagonist MK801
27. Disorientation of hippocampal pyramidal cells and its processes in the schizophrenic patient
28. Acquisition and extinction of a classically conditioned response in hippocampectomized rabbits
29. Latent inhibition and stimulus generalization of the classically conditioned nictitating membrane response in rabbit following dorsal hippocampal ablation
30. Schizophrenia and glutamatergic transmission
31. D-cycloserine increases positive symptoms in chronic schizophrenic patients when administered in addition to antipsychotics: A double-blind parallel placebo-controlled study
32. Functional organization of the limbic system in the process of registration of information: Facts and hypotheses
33. Cognitive deficits in schizophrenia and affective disorders: Evidence for a final common pathway disorder